CI Cigna
Intrinsic value$613.68
Price (at call)$277.51
Margin of safety
+121.1%
vs market (rating basis)
+213.8%
Model unavailable; showing baseline valuation.
⚠ LLM error: empty response; using baseline
The story
Value drivers
| Revenue growth (Y1) | 15.1% |
| Terminal growth | 3.5% |
| Forecast horizon | 10y |
| Target operating margin | 3.6% |
| Years to target margin | 5 |
| Sales-to-capital | 3.84 |
| Beta | 0.50 |
| Failure probability | 0.0% |
| Cost of capital (WACC) | 6.7% |
| Terminal WACC | 8.0% |
Valuation bridge
| PV of explicit FCFF | 26.08B |
| PV of terminal value | 160.08B |
| Equity value | 162.16B |
| ÷ shares → per share | $613.68 |
News
bullish +0.30 · 8 articles
- Cigna Group (CI) Could Be 19% Undervalued As AI Spotlight Meets Growth Narrative
- Is Cigna Group (CI) Still Cheap Based On Its Earnings?
- Is The Pullback In UNH Stock A Glitch Or A Warning?
- Mark Cuban: “No Chance” Radiologists Get Replaced by AI. He Says the Real Target Is Elsewhere
- Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash
- Here's Why Investors Should Stay Neutral on Cigna Stock for Now
- Is CVS Stock a Buy as Earnings Improve but Key Risks Remain Elevated?
- CVS' Q2 EPS Gains From Improved Health Care Benefits Profitability
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 323.96B | 15.1% | 3.6% | 9.36B | 11.09B | -1.72B | -1.61B |
| 2 | 368.84B | 13.9% | 3.6% | 10.66B | 11.67B | -1.02B | -891.04M |
| 3 | 415.17B | 12.6% | 3.6% | 12.00B | 12.05B | -52.00M | -42.76M |
| 4 | 461.95B | 11.3% | 3.6% | 13.35B | 12.17B | 1.18B | 912.11M |
| 5 | 508.01B | 10.0% | 3.6% | 14.68B | 11.98B | 2.70B | 1.95B |
| 6 | 552.09B | 8.7% | 3.6% | 15.96B | 11.47B | 4.49B | 3.04B |
| 7 | 592.86B | 7.4% | 3.6% | 17.13B | 10.60B | 6.53B | 4.14B |
| 8 | 628.95B | 6.1% | 3.6% | 18.18B | 9.39B | 8.79B | 5.22B |
| 9 | 659.11B | 4.8% | 3.6% | 19.05B | 7.84B | 11.20B | 6.23B |
| 10 | 682.18B | 3.5% | 3.6% | 19.71B | 6.00B | 13.71B | 7.14B |
⚠ Extreme gap to market price — large, heavily-covered stocks are rarely mispriced this much; the gap likely embeds disruption, decline, or balance-sheet risk the model underweights. Treat as a flag to investigate, not a verdict.